What is ARNA Panacea (ARNA)
ARNA Panacea is platform which allows not processing of clinical trials data and also support for researchers during R&D phase and marketplace for all types of market participants involved in clinical trials as well as direct sales of final biotech products to customers (patients). The platforms initial purpose is to gain, store and analyze information on all the methods of cancer detection and treatment from all over the world. This would allow researchers getting more accurate and precise knowledge on the subject on one hand, and on the other will provide trustable and accessible proof to all market participants on research results conducted throughout their lifecycle.
Details
Pre-sales: Oct 09, 2017 – Nov 11, 2017
Public sales: Dec 14, 2017 – Feb 09, 2018
Soft cap: 1,000,000 USD
Hard cap: 40,000,000 USD
Raised: 329,227 USD
Legal
Registration country: Russian Federation
Registration year: 2013
Office address: Moscow
Bounty
Bounty: 1%
Translation: 15%
Social media: 45%
Bitcoin talk signature campaign: 30 %
Token info
Ticker: NVER
Type: Utility-token
Token standard: BEP 20
Token distribution:
Seed – 3%
Private/Pre-Sale – 15%
Public Sale – 1%
DEX Liquid Pool – 2.5%
Team – 12%
Marketing – 8%
Treasury – 5%
Advisors – 2.5%
Ecosystem – 51%